DEBBANE RAYMOND 4
4 · LEXICON PHARMACEUTICALS, INC. · Filed May 22, 2023
Insider Transaction Report
Form 4
DEBBANE RAYMOND
Director
Transactions
- Exercise/Conversion
Common Stock
2023-05-21+9,302→ 340,847 total - Exercise/Conversion
Restricted Stock Units
2023-05-21−9,302→ 0 totalExercise: $0.00→ Common Stock (9,302 underlying)
Holdings
- 5,451,204(indirect: By LLC)
Common Stock
Footnotes (2)
- [F1]Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date.
- [F2]Each restricted stock unit represents a contingent right to receive one share of common stock.